Association between dosing of spironolactone and outcomes in heart failure with preserved ejection fraction patients combined with chronic kidney disease------Balance of efficacy and risk

Aims: Few studies have compared the association between dosing of spironolactone and outcomes in patients with heart failure with preserved ejection fraction (HFpEF), and whether spironolactone dose could significantly affect the prognosis of HFpEF patients combined with chronic kidney disease (CKD)...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jun-Feng, Qu, Xiang, Gao, Zhan, Chen, Chang-Xi, Zhang, Feng-Yu, Cheng, Ling, Zhou, Xi, Zhou, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911545/
https://www.ncbi.nlm.nih.gov/pubmed/36778020
http://dx.doi.org/10.3389/fphar.2023.1084442

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911545/
https://www.ncbi.nlm.nih.gov/pubmed/36778020
http://dx.doi.org/10.3389/fphar.2023.1084442

Ejemplares similares